Advertisement

The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity

      Highlights

      • This review links altered microbiome to increased cardiovascular risk (ASCVD).
      • Obesity, T1DM, RA, and SLE share ASCVD etiologies influenced by the microbiome, possibly modifiable by altering gut flora.
      • It emphasizes the need for more research on the gut microbiome in ASCVD.

      Abstract

      Cardiovascular disease associated with obesity and autoimmunity is the leading cause of death in these populations and significant residual risk remains despite current treatment approaches. Obesity, type 1 diabetes mellitus (T1DM), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE) are linked to chronic inflammation, and subjects with these disorders have characteristic shifts in their gut microbiome composition. Recent data suggest that alterations in gut microbial and metabolic composition may be responsible, in part, for induction of chronic inflammation, thus promoting cardiovascular disease. Common microbiome changes observed in obesity, T1DM, RA, and SLE include a decrease in the ratio of bacteria, such as Gram-positive Firmicutes to Gram-negative Bacteroidetes, as well as an overabundance or depletion of certain species, including Prevotella copri. The consequent effects of these shifts include alterations in the metabolic composition of the gut, hyper-activation of toll-like receptor 4 (TLR-4), upregulation of inflammatory pathways, e.g. c-Jun N-terminal kinase and nuclear factor-kappa B (NFκB), increased intestinal permeability, increased C-reactive protein, and increased levels of trimethylamine N-oxide (TMAO). Differential microbiome compositions may also explain sex differences observed in autoimmunity, where a male gut microbiome promotes anti-inflammatory processes as compared to a female pro-inflammatory gut microbiome. Intervention at the level of the microbiota appears to attenuate symptoms in these inflammatory syndromes with probiotic treatment, such as Lactobacilli, playing a uniquely beneficial role in restoring intestinal health, decreasing inflammation, and reducing cardiovascular disease. This review will discuss obesity, T1DM, RA, and SLE in the context of how each unique microbiome profile contributes to elevated cardiovascular risk.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abdeen G.
        • le Roux C.W.
        Mechanism underlying the weight loss and complications of roux-en-Y gastric bypass.
        Rev. Obes. Surg. 2016; 26: 410-421
        • Abdollahi-Roodsaz S.
        • Joosten L.A.B.
        • Koenders M.I.
        • et al.
        Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis.
        J. Clin. Invest. 2008; 118: 205-216
        • Abdallah Ismail N.
        • Ragab S.H.
        • Abd Elbaky A.
        • Shoeib A.R.
        • Alhosary Y.
        • Fekry D.
        Frequency of Firmicutes and Bacteroidetesin gut microbiota in obese and normal weight Egyptian children and adults.
        Arch. Med. Sci. 2011; 7: 501-507
        • Abou-Raya A.
        • Abou-Raya S.
        Inflammation: a pivotal link between autoimmune diseases and atherosclerosis.
        Autoimmun. Rev. 2006; 5: 331-337
        • Achenbach P.
        • Bonifacio E.
        • Koczwara K.
        • Ziegler A.G.
        Natural history of type 1 diabetes.
        Diabetes. Dec 2005; 54: S25-S31
        • Agrawal V.
        • Marinescu V.
        • Agarwal M.
        • McCullough P.A.
        Cardiovascular implications of proteinuria: an indicator of chronic kidney disease.
        Nat. Rev. Cardiol. 2009 Apr 1; 6: 301-311
        • Agus A.
        • Denizot J.
        • Thévenot J.
        • et al.
        Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation.
        Sci. Rep. 2016; 6: 19032
        • Alexander J.L.
        • Wilson I.D.
        • Teare J.
        • Marchesi J.R.
        • Nicholson J.K.
        • Kinross J.M.
        Gut microbiota modulation of chemotherapy efficacy and toxicity.
        Nat. Rev. Gastroenterol. Hepatol. 2017 Jun; 14: 356-365
        • Amar J.
        • Ruidavets J.B.
        • Bal Dit Sollier C.
        • Bongard V.
        • Boccalon H.
        • Chamontin B.
        • Drouet L.
        • Ferrières J.
        Soluble CD14 and aortic stiffness in a population-based study.
        J. Hypertens. 2003; 21: 1869-1877
        • Amaya-Amaya J.
        • Montoya-Sánchez L.
        • Rojas-Villarraga A.
        • Amaya-Amaya J.
        • Montoya-Sánchez L.
        • Rojas-Villarraga A.
        Biomed. Res. Int. 2014; : 367359
        • American Diabetes Association
        Diagnosis and classification of diabetes mellitus.
        Diabetes Care. 2010; 33: S62-S69
        • Bajer L.
        • Kverka M.
        • Kostovcik M.
        • Macinga P.
        • Dvorak J.
        • Stehlikova Z.
        • Brezina J.
        • Wohl P.
        • Spicak J.
        • Drastich P.
        Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
        World J. Gastroenterol. 2017 Jul 7; 23: 4548-4558
        • Boerner B.P.
        • Sarvetnick N.E.
        Type 1 diabetes: role of intestinal microbiome in humans and mice.
        Ann. N. Y. Acad. Sci. 2011; 1243: 103-118
        • Berendsen M.L.T.
        • van Maaren M.C.
        • Arts E.E.A.
        • den Broeder A.A.
        • Popa C.D.
        • Fransen J.
        Anticyclic citrullinated peptide antibodies and rheumatoid factor as risk factors for 10-year cardiovascular morbidity in patients with rheumatoid arthritis: a large inception cohort study.
        J. Rheumatol. 2017 Sep; 44: 1325-1330
        • Brodmann T.
        • Endo A.
        • Gueimonde M.
        • Vinderola G.
        • Kneifel W.
        • de Vos W.M.
        • Salminen S.
        • Gómez-Gallego C.
        Safety of novel microbes for human consumption: practical examples of assessment in the European union.
        Front. Microbiol. 2017 Sep 12; 8: 1725
        • Brown C.T.
        • Davis-Richardson A.G.
        • Giongo A.
        • Gano K.A.
        • Crabb D.B.
        • et al.
        Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes.
        PLoS One. 2011; 6 (e25792)
        • Brusca S.B.
        • Abramson S.B.
        • Scher J.U.
        Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity.
        Curr. Opin. Rheumatol. 2014; 26: 101-107
        • Bujak M.
        • Frangogiannis N.G.
        The role of Interleukin-1 in the pathogenesis of heart disease.
        Arch. Immunol. Ther. Exp. 2009; 57: 165-176
        • Bull M.J.
        • Plummer N.T.
        Part 1: the human gut microbiome in health and disease.
        Integr. Med. 2014 Dec; 13: 17-22
        • Cani P.D.
        • Amar J.
        • Iglesias M.A.
        • Poggi M.
        • Knauf C.
        • Bastelica D.
        • Neyrinck A.M.
        • Fava F.
        • Tuohy K.M.
        • Chabo C.
        • et al.
        Metabolic endotoxemia initiates obesity and insulin resistance.
        Diabetes. 2007; 56: 1761-1772
        • Chakraborti C.K.
        New-found link between microbiota and obesity.
        World J. Gastrointest. Pathophysiol. 2015; 6: 110-119
        • Choi H.K.
        • Hernan M.A.
        • Seeger J.D.
        • Robins J.M.
        • Wolfe F.
        Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.
        Lancet. 2002; 359: 1173-1177
        • Chondronikola M.
        • Harris L.L.
        • Klein S.
        Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass? (Key Symposium).
        J. Intern. Med. 2016; 280: 476-486
        • Chung S.J.
        • Kwon Y.J.
        • Park M.C.
        • Park Y.B.
        • Lee S.K.
        The correlation between increased serum concentrations of Interleukin-6 family cytokines and disease activity in rheumatoid arthritis patients.
        Yonsei Med. J. 2011; 52: 113-120
        • Conlon M.A.
        • Bird A.R.
        The impact of diet and lifestyle on gut microbiota and human health.
        Nutrients. 2014; 7: 17-44
        • Crowson C.S.
        • Liao K.P.
        • Davis J.M.
        • et al.
        Rheumatoid arthritis and cardiovascular disease.
        Am. Heart J. 2013; 166 (e1): 622-628
        • Cunningham M.A.
        • Naga O.S.
        • Eudaly J.G.
        • Scott J.L.
        • Gilkeson G.S.
        Estrogen receptor alpha modulates toll-like receptor signaling in murine lupus.
        Clin. Immunol. 2012; 144: 1-12
        • D'Agostino P.
        • Milano S.
        • Barbera C.
        • Di Bella G.
        • La Rosa M.
        • Ferlazzo V.
        • Farruggio R.
        • Miceli D.M.
        • Miele M.
        • Castagnetta L.
        • Cillari E.
        Sex hormones modulate inflammatory mediators. Macrophagesa.
        Ann. N. Y. Acad. Sci. 1999; 876: 426-429
        • Das U.N.
        Is obesity an inflammatory condition?.
        Nutrition. 2001; 17: 953-966
        • De Ferranti S.D.
        • de Boer I.H.
        • Fonseca V.
        • et al.
        Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the american heart association and american diabetes association.
        Diabetes Care. 2014; 37: 2843-2863
        • De Nicola A.F.
        • Garay L.I.
        • Meyer M.
        • Guennoun R.
        • Sitruk-Ware R.
        • Schumacher M.
        • Gonzalez Deniselle M.C.
        Neurosteroidogenesis and progesterone anti-inflammatory/neuroprotective effects.
        J. Neuroendocrinol. 2018 Feb; 30
      1. Defining Adult Overweight and Obesity. (2016) Retrieved from https://www.cdc.gov/obesity/adult/defining.html.

        • Den Besten G.
        • van Eunen K.
        • Groen A.K.
        • Venema K.
        • Reijngoud D.-J.
        • Bakker B.M.
        The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism.
        JLR (J. Lipid Res.). 2013; 54: 2325-2340
        • Deyab G.
        • Hokstad I.
        • Whist J.E.
        • Småstuen M.C.
        • Agewall S.
        • Lyberg T.
        • Bottazzi B.
        • Meroni P.L.
        • Leone R.
        • Hjeltnes G.
        • Hollan I.
        Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
        PLoS One. 2017; 12 (e0169830)
        • Dhawan S.S.
        • Quyyumi A.A.
        Rheumatoid arthritis and cardiovascular disease.
        Curr. Atherosclerosis Rep. 2008; 10: 128-133
        • Dong L.
        • Wang S.
        • Chen M.
        • Li H.
        • Bi W.
        The activation of macrophage and upregulation of CD40 costimulatory molecule in lipopolysaccharide-induced acute lung injury.
        J. Biomed. Biotechnol. 2008; 2008: 852571
        • Donohoe D.R.
        • Garge N.
        • Zhang X.
        • et al.
        The microbiome and butyrate regulate energy metabolism and autophagy in the Mammalian colon.
        Cell Metabol. 2011; 13: 517-526
        • Durante A.
        • Bronzato S.
        The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations.
        J. Clin. Med. Res. 2015; 7: 379-384
        • Egerer K.
        • Feist E.
        • Rohr U.
        • Pruss A.
        • Burmester G.R.
        • Dörner T.
        Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus.
        Lupus. 2000; 9: 614-621
        • Ellenbroek G.H.J.M.
        • van Puijvelde G.H.M.
        • Anas A.A.
        • et al.
        Leukocyte TLR5 deficiency inhibits atherosclerosis by reduced macrophage recruitment and defective T-cell responsiveness.
        Sci. Rep. 2017; 7: 42688
        • Esmaeili S.A.
        • Mahmoudi M.
        • Momtazi A.A.
        • Sahebkar A.
        • Doulabi H.
        • Rastin M.
        Tolerogenic probiotics: potential immunoregulators in systemic lupus erythematosus.
        J. Cell. Physiol. 2017; 232: 1994-2007
        • Esposito D.
        • Damsud T.
        • Wilson M.
        • Grace M.H.
        • Strauch R.
        • Li X.
        • Lila M.A.
        • Komarnytsky S.
        Black currant anthocyanins attenuate weight gain and improve glucose metabolism in diet-induced obese mice with intact, but not disrupted, gut microbiome.
        J. Agric. Food Chem. 2015; 63: 6172-6180
        • Everard A.
        • Belzer C.
        • Geurts L.
        • Ouwerkerk J.P.
        • Druart C.
        • Bindels L.B.
        • Guiot Y.
        • Derrien M.
        • Muccioli G.G.
        • Delzenne N.M.
        • de Vos W.M.
        • Cani P.D.
        Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity.
        Proc. Natl. Acad. Sci. Unit. States Am. 2013; 110: 9066-9071
        • Faderl M.
        • Noti M.
        • Corazza N.
        • Mueller C.
        Keeping bugs in check: the mucus layer as a critical component in maintaining intestinal homeostasis.
        IUBMB Life. 2015 Apr; 67: 275-285
        • Fernandes J.
        • Su W.
        • Rahat-Rozenbloom S.
        • Wolever T.M.
        • Comelli E.M.
        Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans.
        Nutr. Diabetes. 2014; 4 (e121)
        • Fransen F.
        • van Beek A.A.
        • Borghuis T.
        • et al.
        The impact of gut microbiota on gender-specific differences in immunity.
        Front. Immunol. 2017; 8: 754
        • Ginsberg H.N.
        Insulin resistance and cardiovascular disease.
        J. Clin. Invest. 2000; 106: 453-458
        • Giongo A.
        • Gano K.A.
        • Crabb D.B.
        • et al.
        Toward defining the autoimmune microbiome for type 1 diabetes.
        ISME J. 2011; 5: 82-91
        • Glaros T.G.
        • Chang S.
        • Gilliam E.A.
        • Maitra U.
        • Deng H.
        • Li L.
        Causes and consequences of low grade endotoxemia and inflammatory diseases.
        Front. Biosci. (Schol Ed). 2013; 5: 754-765
        • Graham C.
        • Mullen A.
        • Whelan K.
        Obesity and the gastrointestinal microbiota: a review of associations and mechanisms.
        Nutr. Rev. 2015; 73: 376-385
        • Gregory J.C.
        • Buffa J.A.
        • Org E.
        • Wang Z.
        • Levison B.S.
        • Zhu W.
        • Wagner M.A.
        • Bennett B.J.
        • Li L.
        • DiDonato J.A.
        • Lusis A.J.
        • Hazen S.L.
        Transmission of atherosclerosis susceptibility with gut microbial transplantation.
        J. Biol. Chem. 2015 Feb 27; 290: 5647-5660
        • Gu L.
        • Okada Y.
        • Clinton S.K.
        • Gerard C.
        • Sukhova G.K.
        • Libby P.
        • Rollins B.J.
        Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.
        Mol. Cell. 1998; 2: 275-281
        • Gualtierotti R.
        • Ughi N.
        • Marfia G.
        Ingegnoli F.Practical management of cardiovascular comorbidities in rheumatoid arthritis.
        Rheumatol. Ther. 2017 Dec; 4: 293-308
        • Hevia A.
        • Milani C.
        • López P.
        • Cuervo A.
        • Arboleya S.
        • Duranti S.
        • Turroni F.
        • González S.
        • Suárez A.
        • Gueimonde M.
        • Ventura M.
        Intestinal dysbiosis associated with systemic lupus erythematosus.
        mBio. 2014 Oct 31; 5 (e01548–14)
        • Hollan I.
        • Meroni P.L.
        • Ahearn J.M.
        • Cohen Tervaert J.W.
        • Curran S.
        • Goodyear C.S.
        • Hestad K.A.
        • Kahaleh B.
        • Riggio M.
        • Shields K.
        • Wasko M.C.
        Cardiovascular disease in autoimmune rheumatic diseases.
        Autoimmun. Rev. 2013; 12: 1004-1015
        • Ilhan Z.E.
        • DiBaise J.K.
        • Isern N.G.
        • Hoyt D.W.
        • Marcus A.K.
        • Kang D.W.
        • Crowell M.D.
        • Rittmann B.E.
        • Krajmalnik-Brown R.
        Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding.
        ISME J. 2017; 2047–2058 (Sep;11(9):2047-2058)
        • Iseki K.
        • Iseki C.
        • Kinjo K.
        C-reactive protein is a predictor for developing proteinuria in a screened cohort.
        Nephron Clin. Pract. 2011; 117: c51-c56
        • Jansen M.F.
        • Hollander M.R.
        • van Royen N.
        • Horrevoets A.J.
        • Lutgens E.
        CD40 in coronary artery disease: a matter of macrophages?.
        Basic Res. Cardiol. 2016; 111: 38
        • Kadooka Y.
        • Sato M.
        • Imaizumi K.
        • Ogawa A.
        • Ikuyama K.
        • Akai Y.
        • Okano M.
        • Kagoshima M.
        • Tsuchida T.
        Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial.
        Eur. J. Clin. Nutr. 2010; 64: 636-643
        • Karima T.M.
        • Bukhari S.Z.
        • Ghais M.A.
        • Fatani M.I.
        • Hussain W.M.
        Prevalence of Helicobacter pylori infection in patients with peptic ulcer disease.
        Saudi Med. J. 2006; 27: 621-626
        • Kinoshita K.
        • Kishimoto K.
        • Shimazu H.
        • Nozaki Y.
        • Sugiyama M.
        • Ikoma S.
        • et al.
        Successful treatment with retinoids in patients with lupus nephritis.
        Am. J. Kidney Dis. 2010; 55: 344
        • Knip M.
        • Siljander H.
        The role of the intestinal microbiota in type 1 diabetes mellitus.
        Nat. Rev. Endocrinol. 2016; 12: 154-167
        • Kootte R.S.
        • Levin E.
        • Salojärvi J.
        • Smits L.P.
        • Hartstra A.V.
        • Udayappan S.D.
        • Hermes G.
        • Bouter K.E.
        • Koopen A.M.
        • Holst J.J.
        • Knop F.K.
        • Blaak E.E.
        • Zhao J.
        • Smidt H.
        • Harms A.C.
        • Hankemeijer T.
        • Bergman J.J.G.H.M.
        • Romijn H.A.
        • Schaap F.G.
        • Olde Damink S.W.M.
        • Ackermans M.T.
        • Dallinga-Thie G.M.
        • Zoetendal E.
        • de Vos W.M.
        • Serlie M.J.
        • Stroes E.S.G.
        • Groen A.K.
        • Nieuwdorp M.
        Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition.
        Cell Metabol. 2017 Oct 3; 26 (e6.): 611-619
        • Kootte R.S.
        • Vrieze A.
        • Holleman F.
        • Dallinga-Thie G.M.
        • Zoetendal E.G.
        • de Vos W.M.
        • Groen A.K.
        • Hoekstra J.B.L.
        • Stroes E.S.
        • Nieuwdorp M.
        The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes.
        Obes. Metabol. 2012; 14: 112-120
        • Kremers H.M.
        • Crowson C.S.
        • Therneau T.M.
        • Roger V.L.
        • Gabriel S.E.
        High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study.
        Arthritis Rheum. 2008; 14: 2268-2274
        • Kuipers E.J.
        • Thijs J.C.
        • Festen H.P.
        The prevalence of Helicobacter pylori in peptic ulcer disease.
        Aliment. Pharmacol. Ther. 1995; 9: 59-69
        • Lavie C.J.
        • Arena R.
        • Alpert M.A.
        • Milani R.V.
        • Ventura H.O.
        Management of cardiovascular diseases in patients with obesity.
        Nat. Rev. Cardiol. 2018 Jan; 15: 45-56
        • Ley K.
        • Miller Y.I.
        • Hedrick C.C.
        Monocyte and macrophage dynamics during atherogenesis.
        Arterioscler. Thromb. Vasc. Biol. 2011; 31: 1506-1516
        • Ley R.E.
        • Turnbaugh P.J.
        • Klein S.
        • Gordon J.I.
        Microbial ecology: human gut microbes associated with obesity.
        Nature. 2006; 444: 1022-1023
        • Ley R.E.
        Gut microbiota in 2015: Prevotella in the gut: choose carefully.
        Nat. Rev. Gastroenterol. Hepatol. 2016; 13: 69-70
      2. Lupus Detailed Fact Sheet. (2017) Retrieved from https://www.cdc.gov/lupus/facts/detailed.html.

        • Maeda Y.
        • Kurakawa T.
        • Umemoto E.
        • Motooka D.
        • Ito Y.
        • Gotoh K.
        • Hirota K.
        • Matsushita M.
        • Furuta Y.
        • Narazaki M.
        • Sakaguchi N.
        • Kayama H.
        • Nakamura S.
        • Iida T.
        • Saeki Y.
        • Kumanogoh A.
        • Sakaguchi S.
        • Takeda K.
        Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine.
        Arthritis Rheum. 2016; 68: 2646-2661
        • Manrique C.
        • Lastra G.
        • Sowers J.R.
        New insights into insulin action and resistance in the vasculature.
        Ann. N. Y. Acad. Sci. 2014; 1311: 138-150
        • Marietta E.V.
        • Murray J.A.
        • Luckey D.H.
        • Jeraldo P.R.
        • Lamba A.
        • Patel R.
        • Luthra H.S.
        • Mangalam A.
        • Taneja V.
        Suppression of inflammatory arthritis by human gut-derived Prevotella histicola in humanized mice.
        Arthritis Rheumatol. 2016; 68: 2878-2888
        • Mazloom Z.
        • Yousefinejad A.
        • Dabbaghmanesh M.H.
        Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: a clinical trial.
        Iran. J. Med. Sci. 2013 Mar; 38: 38-43
        • McInnes I.B.
        • Thompson L.
        • Giles J.T.
        • Bathon J.M.
        • Salmon J.E.
        • Beaulieu A.D.
        • Codding C.E.
        • Carlson T.H.
        • Delles C.
        • Lee J.S.
        • Sattar N.
        Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study.
        Ann. Rheum. Dis. 2013; : 1-9
        • McMahon M.
        • Hahn B.H.
        • Skaggs B.J.
        Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.
        Expet Rev. Clin. Immunol. 2011; 7: 227-241
        • Monk J.M.
        • Lepp D.
        • Wu W.
        • Graf D.
        • Hutchinson A.L.
        • Robinson L.E.
        • Power K.A.
        Navy bean supplementation in obesity increases Akkermansia muciniphila abundance and attenuates obesity related impairments in gut barrier function.
        Faseb. J. 2016; 30
        • Moreno-Indias I.
        • Sánchez-Alcoholado L.
        • García-Fuentes E.
        • Cardona F.
        • Queipo-Ortuño M.I.
        • Tinahones F.J.
        Insulin resistance is associated with specific gut microbiota in appendix samples from morbidly obese patients.
        Am. J. Transl. Res. 2016; 8: 5672-5684
        • Mu Q.
        • Zhang H.
        • Luo X.M.
        SLE: another autoimmune disorder influenced by microbes and diet?.
        Front. Immunol. 2015; 6: 608
        • Ortona E.
        • Pierdominici M.
        • Maselli A.
        • Veroni C.
        • Aloisi F.
        • Shoenfeld Y.
        Sex-based differences in autoimmune diseases.
        Ann. Ist. Super Sanita. 2016; 52: 205-212
        • Okada H.
        • Kuhn C.
        • Feillet H.
        • Bach J.-F.
        The “hygiene hypothesis” for autoimmune and allergic diseases: an update.
        Clin. Exp. Immunol. 2010; 160: 1-9
        • Pedersen H.K.
        • Gudmundsdottir V.
        • Nielsen H.B.
        • Hyotylainen T.
        • Nielsen T.
        • Jensen B.A.
        • Forslund K.
        • Hildebrand F.
        • Prifti E.
        • Falony G.
        • Le Chatelier E.
        • Levenez F.
        • Doré J.
        • Mattila I.
        • Plichta D.R.
        • Pöhö P.
        • Hellgren L.I.
        • Arumugam M.
        • Sunagawa S.
        • Vieira-Silva S.
        • Jørgensen T.
        • Holm J.B.
        • Trošt K.
        • MetaHIT Consortium, Kristiansen K, Brix S, Raes J, Wang J, Hansen T, Bork P, Brunak S, Oresic M, Ehrlich SD, Pedersen O
        Human gut microbes impact host serum metabolome and insulin sensitivity.
        Nature. 2016 Jul 21; 535: 376-381
        • Pérez de Lema G.
        • Lucio-Cazaña F.J.
        • Molina A.
        • Luckow B.
        • Schmid H.
        • de Wit C.
        • Moreno-Manzano V.
        • Banas B.
        • Mampaso F.
        • Schlöndorff D.
        Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease.
        Kidney Int. 2004; 66: 1018-1028
        • Perry R.J.
        • Peng L.
        • Barry N.A.
        • et al.
        Acetate mediates a microbiome-brain-β cell axis promoting metabolic syndrome.
        Nature. 2016; 534: 213-217
        • Petri M.A.
        • Kiani A.N.
        • Post W.
        • Christopher-Stine L.
        • Magder L.S.
        Lupus atherosclerosis prevention study (LAPS).
        Ann. Rheum. Dis. 2011 May; 70: 760-765
        • Petrich B.G.
        • Eloff B.C.
        • Lerner D.L.
        • Kovacs A.
        • Saffitz J.E.
        • Rosenbaum D.S.
        • et al.
        Targeted activation of c-jun n-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects.
        J. Biol. Chem. 2004; 279: 15330-15338
        • Pianta A.
        • Arvikar S.
        • Strle K.
        • Drouin E.E.
        • Wang Q.
        • Costello C.E.
        • Steere A.C.
        Evidence of the immune relevance of Prevotella copri, a gut microbe, in patients with rheumatoid arthritis.
        Arthritis Rheum. 2017; 69: 964-975
        • Plovier H.
        • Everard A.
        • Druart C.
        • Depommier C.
        • Van Hul M.
        • Geurts L.
        • Chilloux J.
        • Ottman N.
        • Duparc T.
        • Lichtenstein L.
        • Myridakis A.
        • Delzenne N.M.
        • Klievink J.
        • Bhattacharjee A.
        • van der Ark K.C.
        • Aalvink S.
        • Martinez L.O.
        • Dumas M.E.
        • Maiter D.
        • Loumaye A.
        • Hermans M.P.
        • Thissen J.P.
        • Belzer C.
        • de Vos W.M.
        • Cani P.D.
        A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.
        Nat. Med. 2017 Jan; 23: 107-113
        • Poirier P.
        • Giles T.D.
        • Bray G.A.
        • Hong Y.
        • Stern J.S.
        • Pi-Sunyer F.X.
        • Eckel R.H.
        Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss.
        Circulation. 2006; 113: 898-918
        • Reiser J.
        • von Gersdorff G.
        • Loos M.
        • Oh J.
        • Asanuma K.
        • et al.
        Induction of B7-1 in podocytes is associated with nephrotic syndrome.
        J. Clin. Invest. 2004; 113: 1390-1397
        • Reiss A.B.
        • Siegart N.M.
        • DeLeon J.
        Interleukin-6 in atherosclerosis: atherogenic or atheroprotective?.
        Clin. Lipidol. 2017; 12: 14-23
        • Ridaura V.K.
        • Faith J.J.
        • Rey F.E.
        • Cheng J.
        • Duncan A.E.
        • Kau A.L.
        • Griffin N.W.
        • Lombard V.
        • Henrissat B.
        • Bain J.R.
        • Muehlbauer M.J.
        • Ilkayeva O.
        • Semenkovich C.F.
        • Funai K.
        • Hayashi D.K.
        • Lyle B.J.
        • Martini M.C.
        • Ursell L.K.
        • Clemente J.C.
        • Van Treuren W.
        • Walters W.A.
        • Knight R.
        • Newgard C.B.
        • Heath A.C.
        • Gordon J.I.
        Gut microbiota from twins discordant for obesity modulate metabolism in mice.
        Science. 2013 Sep 6; 341: 1241214
        • Ridker P.M.
        • Buring J.E.
        • Shih J.
        • Matias M.
        • Hennekens C.H.
        Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.
        Circulation. 1998; 98: 731-733
        • Roesch R.F.W.
        • Lorca G.L.
        • Casella G.
        • Giongo A.
        • Naranjo A.
        • Pionzo A.M.
        • et al.
        Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model.
        ISME J. 2009; 3: 536-548
        • Roselló-Lletí E.
        • Rivera M.
        • Bertomeu V.
        • Cortés R.
        • Jordán A.
        • González-Molina A.
        Interleukin-4 and cardiac fibrosis in patients with heart failure.
        Rev. Esp. Cardiol. 2007; 60: 777-780
        • Scher J.U.
        • Littman D.R.
        • Abramson S.B.
        Microbiome in inflammatory arthritis and human rheumatic diseases.
        Arthritis Rheum. 2016; 68: 35-45
        • Scher J.U.
        • Sczesnak A.
        • Longman R.S.
        • et al.
        Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis.
        in: eLife. vol. 2. 2013 (e01202)
        • Schmidt-Arras D.
        • Rose-John S.
        IL-6 pathway in the liver: from physiopathology to therapy.
        J. Hepatol. 2016; 64: 1403-1415
        • Scott D.L.
        • Wolfe F.
        • Huizinga T.W.J.
        Rheumatoid arthritis.
        Lancet. 2010; 376: 1094-1108
        • Sinicato N.A.
        • Cardoso P.A.
        • da S.
        • Appenzeller S.
        Risk factors in cardiovascular disease in systemic lupus erythematosus.
        Curr. Cardiol. Rev. 2013; 9: 15-19
        • Slim I.B.H.S.
        Cardiovascular risk in type 1 diabetes mellitus.
        Indian J. Endocrinol. Metabol. 2013; 17: S7-S13
        • Solomon D.H.
        • Kremer J.
        • Curtis J.R.
        • Hochberg M.C.
        • Reed G.
        • Tsao P.
        Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity.
        Ann. Rheum. Dis. 2010; : 1920-1925
        • Spinelli F.R.
        • Pecani A.
        • Ciciarello F.
        • Colasanti T.
        • Di Franco M.
        • Miranda F.
        • Conti F.
        • Valesini G.
        • Alessandri C.
        Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients.
        BMC Musculoskelet. Disord. 2017; 18: 214
        • Suganami T.
        • Tanimoto-Koyama K.
        • Nishida J.
        • et al.
        Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages.
        Arterioscler. Thromb. Vasc. Biol. 2007; 27: 84-91
        • Symmons D.P.
        • Gabriel S.E.
        Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.
        Nat. Rev. Rheumatol. 2011; 7: 399-408
        • Tailford L.E.
        • Crost E.H.
        • Kavanaugh D.
        • Juge N.
        Mucin glycan foraging in the human gut microbiome.
        Front. Genet. 2015; 6: 81
        • Tripathy A.
        • Khanna S.
        • Padhan P.
        • Smita S.
        • Raghav S.
        • Gupta B.
        Direct recognition of LPS drive TLR4 expressing CD8+ T cell activation in patients with rheumatoid arthritis.
        Sci. Rep. 2017 Apr 19; 7: 933
        • Uramoto K.M.
        • Michet Jr., C.J.
        • Thumboo J.
        • Sunku J.
        • O'Fallon W.M.
        • Gabriel S.E.
        Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.
        Arthritis Rheum. 1999; 42: 46-50
        • Valen G.
        • Yan Z.
        • Hansson G.K.
        Nuclear factor kappa-B and the heart.
        J. Am. Coll. Cardiol. 2001; 38: 307-314
        • Valladares R.
        • Sankar D.
        • Li N.
        • Williams E.
        • Lai K.K.
        • Abdelgeliel A.S.
        • Gonzalez C.F.
        • Wasserfall C.H.
        • Larkin III, J.
        • Schatz D.
        • Atkinson M.A.
        Lactobacillus johnsonii N6. 2 mitigates the development of type 1 diabetes in BB-DP rats.
        PLoS One. 2010 May 6; 5 (e10507)
        • Vijay-Kumar M.
        • Aitken J.D.
        • Carvalho F.A.
        • Cullender T.C.
        • Mwangi S.
        • Srinivasan S.
        • Sitaraman S.V.
        • Knight R.
        • Ley R.E.
        • Gewirtz A.T.
        Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5.
        Science (New York, NY). 2010; 328: 228-231
        • Vrieze A.
        • Van Nood E.
        • Holleman F.
        • Salojärvi J.
        • Kootte R.S.
        • Bartelsman J.F.
        • Dallinga-Thie G.M.
        • Ackermans M.T.
        • Serlie M.J.
        • Oozeer R.
        • Derrien M.
        • Druesne A.
        • Van Hylckama Vlieg J.E.
        • Bloks V.W.
        • Groen A.K.
        • Heilig H.G.
        • Zoetendal E.G.
        • Stroes E.S.
        • de Vos W.M.
        • Hoekstra J.B.
        • Nieuwdorp M.
        Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.
        Gastroenterology. 2012; 143 (e7): 913-916
      3. What is Rheumatoid Arthritis?, (n.d.) Retrieved from http://www.arthritis.org/about-arthritis/types/rheumatoid-arthritis/what-is-rheumatoid-arthritis.php.

        • Yahagi K.
        • Kolodgie F.D.
        • Lutter C.
        • Mori H.
        • Romero M.E.
        • Finn A.V.
        • Virmani R.
        Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus.
        Arterioscler. Thromb. Vasc. Biol. 2017; 37: 191-204
        • Yu X.H.
        • Zhang J.
        • Zheng X.L.
        • Yang Y.H.
        • Tang C.K.
        Interferon-γ in foam cell formation and progression of atherosclerosis.
        Clin. Chim. Acta. 2015 Feb 20; 441: 33-43
        • Yurkovetskiy L.
        • Burrows M.
        • Khan A.A.
        • Graham L.
        • Volchkov P.
        • Becker L.
        • Antonopoulos D.
        • Umesaki Y.
        • Chervonsky A.V.
        Gender bias in autoimmunity is influenced by microbiota.
        Immunity. 2013; 39
        • Zhang G.
        • Han J.
        • Welch E.J.
        • Ye R.D.
        • Voyno-Yasenetskaya T.A.
        • Malik A.B.
        • et al.
        Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway.
        J. Immunol. 2009; 182: 7997-8004
        • Zhang H.
        • Liao X.
        • Sparks J.B.
        • Luo X.M.
        Dynamics of gut microbiota in autoimmune lupus.
        in: Schloss P.D. Applied and Environmental Microbiology. 2014 (80(24):7551–7560)
        • Zhu W.
        • Wang Z.
        • Tang W.H.W.
        • Hazen S.L.
        Gut microbe-generated trimethylamine N-Oxide from dietary choline is prothrombotic in subjects.
        Circulation. 2017; 135: 1671-1673
        • Zinger H.
        • Sherer Y.
        • Shoenfeld Y.
        Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.
        Clin. Rev. Allergy Immunol. 2009 Aug; 37: 20-28
        • Endesfelder D.
        • Engel M.
        • Davis-Richardson A.G.
        • Ardissone A.N.
        • Achenbach P.
        • Hummel S.
        • Winkler C.
        • Atkinson M.
        • Schatz D.
        • Triplett E.
        • Ziegler A.G.
        • zu Castell W.
        Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate production.
        Microbiome. 2016 Apr 26; 4: 17